The results demonstrate that KEAP1 mutations activate the NRF2 antioxidant program and promote LUAD progression in concert with mutant KRAS (124), demonstrating that cancer cells can overcome oxidative stress barriers during tumorigenesis (125–131). Here, KRAS is linked to cancer.